Liposomal Nanoconfinement Enables Type I Photodynamic Conversion for Synergistic Cancer Photothermal‐Immunotherapy
Open Access
- 15 February 2026
- journal article
- Published by Wiley in Advanced Science
- Vol. 13 (23) , e15013
Abstract
Type‐I photodynamic therapy (PDT) agents offer a promising approach for treating hypoxic tumors. However, previous reports mainly focused on thermodynamic modulation through molecular engineering to block the Type‐II energy transfer pathway. Herein, we present a facile strategy to realize the conversion of Type II to Type I PDT by integrating liposomal confinement and electron/hydrogen transfer pathway. A multifunctional nanoplatform, RhM‐R837@Lip was developed, which facilitates an efficient shift from Type II to Type I for hemicyanine‐based photosensitizer (PS) by suppressing singlet oxygen ( 1 O 2 ) generation while promoting superoxide anion (O 2 •− ) and hydroxyl radical (•OH). Lipids serve as electron donors, facilitating electron transfer to form PS radical anions. Additionally, liposomal nanoconfinement acts as a photothermal nanoreactor, achieving a photothermal conversion efficiency as high as 56.1%. Co‐encapsulation of immunoadjuvant R837 stimulates systemic immune responses, synergistically enhancing tumor eradication. This radical‐switching behavior, driven by liposomal nanoconfinement and the donor–π–acceptor (D‐π‐A) structural configuration, modulates electron transfer pathways to favor Type‐I photoreactions. The RhM‐R837@Lip nanoplatform provides a versatile, integrated strategy to overcome hypoxic tumor microenvironments, improving PDT and photocatalytic performance, and effectively inhibits tumor metastasis.Keywords
Funding Information
- National Key Research and Development Program of China (2022YFA1207600)
- National Natural Science Foundation of China (32570817)
- National Natural Science Foundation of China (12535020)
- National Natural Science Foundation of China (12275302)
- National Natural Science Foundation of China (12275300)
- Natural Science Foundation of Beijing Municipality (Z230008)
- Chinese Academy of Sciences (E4545CU210)
This publication has 59 references indexed in Scilit:
- Heterodimeric Photosensitizer as Radical Generators to Promoting Type I Photodynamic Conversion for Hypoxic Tumor TherapyAdvanced Materials, 2025
- Electron Transfer Mediator Modulates Type II Porphyrin‐Based Metal–Organic Framework Photosensitizers for Type I Photodynamic TherapyAngewandte Chemie, 2024
- Biomimetic MOF‐Based Nano‐Immunoactivator via Disruption of Ion Homeostasis for Strengthened Tumor Microwave‐ImmunotherapyAdvanced Functional Materials, 2024
- A Dual‐Function Hemicyanine Material with Highly Efficient Photothermal and Photodynamic Effect Used for Tumor TherapyAdvanced Healthcare Materials, 2023
- Lipid Droplet Targeting Type I Photosensitizer for Ferroptosis via Lipid Peroxidation AccumulationAdvanced Materials, 2023
- A Comparison of Cellular Uptake Mechanisms, Delivery Efficacy, and Intracellular Fate between Liposomes and Extracellular VesiclesAdvanced Healthcare Materials, 2023
- Achieving Efficient NIR‐II Type‐I Photosensitizers for Photodynamic/Photothermal Therapy upon Regulating Chalcogen ElementsAdvanced Materials, 2021
- Silk‐Inspired In Situ Hydrogel with Anti‐Tumor Immunity Enhanced Photodynamic Therapy for Melanoma and Infected Wound HealingAdvanced Functional Materials, 2021
- Massively Evoking Immunogenic Cell Death by Focused Mitochondrial Oxidative Stress using an AIE Luminogen with a Twisted Molecular StructureAdvanced Materials, 2019
- Recent Progresses in Phototherapy‐Synergized Cancer ImmunotherapyAdvanced Functional Materials, 2018